193 related articles for article (PubMed ID: 32171356)
1. 'We're kidding ourselves if we say that contraception is accessible': a qualitative study of general practitioners' attitudes towards adolescents' use of long-acting reversible contraceptives (LARC).
Duncan R; Paterson H; Anderson L; Pickering N
J Prim Health Care; 2019 Jul; 11(2):138-145. PubMed ID: 32171356
[TBL] [Abstract][Full Text] [Related]
2. A qualitative analysis of adolescents' opinions of proactive long-acting reversible contraceptive (LARC) provision.
Duncan R; Paterson H; Anderson L; Pickering N
N Z Med J; 2019 Jan; 132(1488):38-48. PubMed ID: 31851660
[TBL] [Abstract][Full Text] [Related]
3. Barriers to the prescription of LARCs in general practice in New Zealand-a qualitative research study.
McGinn O; Fulcher HJ; Arroll B; McCowan L
N Z Med J; 2019 Dec; 132(1507):63-69. PubMed ID: 31830018
[TBL] [Abstract][Full Text] [Related]
4. Can Pediatricians Provide Long-Acting Reversible Contraception?
Norris AH; Pritt NM; Berlan ED
J Pediatr Adolesc Gynecol; 2019 Feb; 32(1):39-43. PubMed ID: 30278228
[TBL] [Abstract][Full Text] [Related]
5. Role of social network in decision making for increasing uptake and continuing use of long acting reversible (LARC) methods in Pakistan.
Sarfraz M; Hamid S; Rawstorne P; Ali M; Jayasuriya R
Reprod Health; 2021 May; 18(1):96. PubMed ID: 34001169
[TBL] [Abstract][Full Text] [Related]
6. Dual-Method Contraception Among Adolescents and Young People: Are Long-Acting Reversible Contraception Users Different? A Qualitative Study.
Raidoo S; Tschann M; Elia J; Kaneshiro B; Soon R
J Pediatr Adolesc Gynecol; 2020 Feb; 33(1):45-52. PubMed ID: 31585164
[TBL] [Abstract][Full Text] [Related]
7. Views of general practitioners on providing contraceptive advice and long-acting reversible contraception at the 6-week postnatal visit: a qualitative study.
Lunniss H; Cameron S; Chen ZE
J Fam Plann Reprod Health Care; 2016 Apr; 42(2):99-106. PubMed ID: 26311649
[TBL] [Abstract][Full Text] [Related]
8. Long-acting reversible contraception for adolescents and young adults - a cross-sectional study of women and general practitioners in Oslo, Norway.
Bratlie M; Aarvold T; Skårn ES; Lundekvam JA; Nesheim BI; Askevold ET
Eur J Contracept Reprod Health Care; 2014 Jun; 19(3):194-202. PubMed ID: 24742172
[TBL] [Abstract][Full Text] [Related]
9. ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
Obstet Gynecol; 2018 May; 131(5):e130-e139. PubMed ID: 29683910
[TBL] [Abstract][Full Text] [Related]
10. A Qualitative Study Exploring Contraceptive Practices and Barriers to Long-Acting Reversible Contraceptive Use in a Sample of Adolescents Living in the Southern United States.
Coates C; Gordon CM; Simpson T
J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):605-609. PubMed ID: 30012426
[TBL] [Abstract][Full Text] [Related]
11. Pediatricians' Attitudes and Beliefs about Long-Acting Reversible Contraceptives Influence Counseling.
Berlan ED; Pritt NM; Norris AH
J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):47-52. PubMed ID: 27639750
[TBL] [Abstract][Full Text] [Related]
12. Sustainable and effective methods to increase long-acting reversible contraception uptake from the ACCORd general practice trial.
Taft A; Watson CJ; McCarthy E; Black KI; Lucke J; McGeechan K; Haas M; McNamee K; Peipert JF; Mazza D
Aust N Z J Public Health; 2022 Aug; 46(4):540-544. PubMed ID: 35557481
[TBL] [Abstract][Full Text] [Related]
13. Acceptability of immediate postpartum and post-abortion long-acting reversible contraception provision to adolescents: A systematic review.
Buckingham P; Moulton JE; Subasinghe AK; Amos N; Mazza D
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):629-640. PubMed ID: 33608901
[TBL] [Abstract][Full Text] [Related]
14. Barriers and Facilitators to Adolescents' Use of Long-Acting Reversible Contraceptives.
Pritt NM; Norris AH; Berlan ED
J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):18-22. PubMed ID: 27477904
[TBL] [Abstract][Full Text] [Related]
15. A Qualitative Study of Prescription Contraception Use: The Perspectives of Users, General Practitioners and Pharmacists.
Sweeney LA; Molloy GJ; Byrne M; Murphy AW; Morgan K; Hughes CM; Ingham R
PLoS One; 2015; 10(12):e0144074. PubMed ID: 26633191
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and associations of prescribing of long-acting reversible contraception by general practitioner registrars: a secondary analysis of ReCEnT data.
Turner R; Tapley A; Sweeney S; Davey A; Holliday E; van Driel M; Henderson K; Ball J; Morgan S; Spike N; FitzGerald K; Magin P
BMJ Sex Reprod Health; 2020 Jul; 46(3):218-225. PubMed ID: 31964777
[TBL] [Abstract][Full Text] [Related]
17. From awareness to usage of long-acting reversible contraceptives: Results of a large European survey.
Caetano C; Bliekendaal S; Engler Y; Lombardo M
Int J Gynaecol Obstet; 2020 Dec; 151(3):366-376. PubMed ID: 32852798
[TBL] [Abstract][Full Text] [Related]
18. Midwives' experiences and views of giving postpartum contraceptive advice and providing long-acting reversible contraception: a qualitative study.
McCance K; Cameron S
J Fam Plann Reprod Health Care; 2014 Jul; 40(3):177-83. PubMed ID: 24500869
[TBL] [Abstract][Full Text] [Related]
19. A Qualitative Study of Factors That Influence Contraceptive Choice among Adolescent School-Based Health Center Patients.
Hoopes AJ; Gilmore K; Cady J; Akers AY; Ahrens KR
J Pediatr Adolesc Gynecol; 2016 Jun; 29(3):259-64. PubMed ID: 26477942
[TBL] [Abstract][Full Text] [Related]
20. Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial protocol.
Mazza D; Black K; Taft A; Lucke J; McGeechan K; Haas M; McKay H; Peipert JF
BMJ Open; 2016 Oct; 6(10):e012491. PubMed ID: 27855100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
